Skip to main content

Published locations for FDA panel not ready to recommend quizartinib approval for FLT3-ITD+ AML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA panel not ready to recommend quizartinib approval for FLT3-ITD+ AML

User login

  • Reset your password
  • /content/fda-panel-not-ready-recommend-quizartinib-approval-flt3-itd-aml
  • /hematologynews/article/200936/aml/fda-panel-not-ready-recommend-quizartinib-approval-flt3-itd-aml
  • /oncologypractice/article/200936/aml/fda-panel-not-ready-recommend-quizartinib-approval-flt3-itd-aml
  • /hematology-oncology/article/200936/aml/fda-panel-not-ready-recommend-quizartinib-approval-flt3-itd
  • /hematologytimes/article/200936/aml/fda-panel-not-ready-recommend-quizartinib-approval-flt3-itd-aml